Exact Sciences is a cancer diagnostics company focused on helping people live fuller lives through better health. Its work spans cancer prevention, screening, early detection, and therapy guidance, with tests designed to assess hereditary risk, detect signs of cancer, and examine tumor genomic alterations after diagnosis. The company serves patients and healthcare providers, and collaborates with medical experts, researchers, institutions, advocacy partners, and policymakers to advance cancer care.

Its portfolio includes Cancerguard, a multi-cancer early detection test; Cologuard and Cologuard Plus for colorectal cancer screening; and tests such as Oncodetect, OncoExTra, Oncoguard Liver, Riskguard, and SimpleScreen CRC. Exact Sciences also offers Oncotype DX tests for breast and colon cancer, including products that help inform treatment decisions. Through research, clinical studies, publications, and laboratory expertise, the company works to improve how cancer is detected, diagnosed, and managed. It also provides customer support and resources for patients, providers, health systems, and researchers, while sharing company news, science updates, and career opportunities.